$99.02 +0.74 (%) Johnson & Johnson - NYSE

Jul. 28, 2015 | 04:00 PM

Partner Headlines

  1. Wakefulness Drug Xyrem Keeps Jazz Pharmaceuticals Up

    IBD | Jul. 28, 2015 | 16:03PM EST
  2. ETFs For The Next Pharma Takeover Candidates

    Benzinga | Jul. 28, 2015 | 13:08PM EST
  3. Biogen Plunges On Slashed Guidance; AbbVie Q2 Mixed

    IBD | Jul. 24, 2015 | 11:44AM EST
  4. Novartis' Mixed Q2: Sandoz Booms, Alcon Struggles

    IBD | Jul. 21, 2015 | 13:15PM EST
  5. Who Doesn't Like Top Stocks With Big, Steady Payout?

    IBD | Jul. 20, 2015 | 18:05PM EST
  6. Pennsylvania Trust Co.'s Top Sales in Q2 2015

    GuruFocus | Jul. 19, 2015 | 22:47PM EST
  7. 6 Big-Cap Drugmakers Reporting Earnings Next Week

    IBD | Jul. 18, 2015 | 08:02AM EST
  8. Yacktman Fund Reduces Stakes in Six of its Most Valuable Holdings

    GuruFocus | Jul. 15, 2015 | 19:10PM EST
  9. What Will Gilead Buy Next? 4 Possible Targets

    IBD | Jul. 15, 2015 | 16:44PM EST
  10. Johnson & Johnson Profit Dips

    IBD | Jul. 14, 2015 | 18:54PM EST
  11. J&J Earnings Beat Views As Pharma Leads Way Again

    IBD | Jul. 14, 2015 | 11:18AM EST
  12. Stocks Creep Up In Mixed Trade; Micron, GoPro, Ambarella Climb

    IBD | Jul. 14, 2015 | 10:34AM EST
  13. Stock Futures Tightly Mixed; Micron, GoPro, JPMorgan Gain Ground

    IBD | Jul. 14, 2015 | 09:09AM EST
  14. Futures Sag Amid Iran Deal, Earnings, Data

    FoxBusiness | Jul. 14, 2015 | 08:45AM EST
  15. Johnson & Johnson Q2 Earnings Top Expectations

    Benzinga | Jul. 14, 2015 | 08:12AM EST
  16. 7 Stocks You Should Be Watching Today

    Benzinga | Jul. 14, 2015 | 04:14AM EST
  17. Stock Futures Rise On Greek Deal; Anacor, Edwards Lifesciences Rising

    IBD | Jul. 13, 2015 | 09:13AM EST
  18. Designing a Retirement Portfolio That's Just Right For You

    GuruFocus | Jul. 10, 2015 | 15:22PM EST
  19. Strong Dollar? Not So Good For Johnson & Johnson Earnings

    Benzinga | Jul. 10, 2015 | 11:41AM EST
  20. Horizon Makes Unsolicited $3 Billion Bid For Depomed

    IBD | Jul. 7, 2015 | 10:27AM EST
  21. S&P 500 Index Futures Trading Higher

    Benzinga | Jun. 26, 2015 | 11:38AM EST
  22. Where Can Mega-Drug Stock Gilead Sciences Go Now?

    IBD | Jun. 22, 2015 | 13:56PM EST
  23. The Surprising Llink Between Volatility And Returns

    GuruFocus | Jun. 22, 2015 | 13:18PM EST
  24. Follow Bill Ackman in Valeant Pharmaceuticals

    GuruFocus | Jun. 19, 2015 | 12:32PM EST
  25. A 'Gay Friendly' Portfolio Includes Apple, Microsoft & Disney...And It Beats The Market

    Benzinga | Jun. 19, 2015 | 10:53AM EST
  26. Baozun: The Little Guy Behind Big Brands In China

    IBD | Jun. 17, 2015 | 17:59PM EST
  27. An app that tracks the sniffles

    IBD | Jun. 15, 2015 | 18:44PM EST
  28. Johnson & Johnson Looks Attractive

    GuruFocus | Jun. 12, 2015 | 12:41PM EST
  29. IBM Watson Engages Industry With New Era Of Computing

    IBD | Jun. 12, 2015 | 09:34AM EST
  30. J&J launches diabetes project

    IBD | Jun. 11, 2015 | 18:57PM EST
  31. What The Great Recession Taught Me About Dividend Growth Investing

    GuruFocus | Jun. 11, 2015 | 17:08PM EST
  32. Isis, Biogen Rare-Disease Drug Aids Infant Survival

    IBD | Jun. 11, 2015 | 12:58PM EST
  33. S&P 500 Index Futures Trading Higher

    Benzinga | Jun. 11, 2015 | 11:45AM EST
  34. Johnson and Johnson CEO: Cancer Research Is Paying Off

    FoxBusiness | Jun. 11, 2015 | 11:21AM EST
  35. How Warren Buffett Interprets Financial Statements Part 1

    GuruFocus | Jun. 10, 2015 | 11:09AM EST
  36. Bill Frels Adds to 63 Existing Stakes in First Quarter

    GuruFocus | Jun. 8, 2015 | 18:40PM EST
  37. S&P 500 Index Futures Trading Lower In Choppy Session

    Benzinga | Jun. 8, 2015 | 10:47AM EST
  38. S&P 500 Index Futures Trading Lower In Volatile Session

    Benzinga | Jun. 5, 2015 | 11:08AM EST
  39. 10 Reasons Why Growth Stocks Can Be Appropriate for Retired Investors

    GuruFocus | Jun. 4, 2015 | 16:37PM EST
  40. Halozyme Stock Hits New High On AbbVie Collaboration

    IBD | Jun. 3, 2015 | 15:28PM EST
  41. Healthcare, Yen And Oil ETFs To Watch This Week

    Benzinga | May. 31, 2015 | 10:59AM EST
  42. Three Reasons Why Retired Investors Should Put Maximum Focus and Weight On Dividends

    GuruFocus | May. 29, 2015 | 17:13PM EST
  43. Johnson & Johnson

    IBD | May. 28, 2015 | 18:54PM EST
  44. James Barrow increases his position in Johnson and Johnson

    GuruFocus | May. 28, 2015 | 16:17PM EST
  45. PRIMECAP Sells Portions of Its Top Two Stakes

    GuruFocus | May. 27, 2015 | 19:36PM EST
  46. IBM's Watson Now Looks To Disrupt Oil & Gas Industry

    IBD | May. 27, 2015 | 13:16PM EST
  47. Gilead-GlobeImmune Hepatitis B Drug Fails Trial

    IBD | May. 27, 2015 | 12:57PM EST
  48. 11 Reasons to be a Dividend Growth Investor

    GuruFocus | May. 27, 2015 | 11:39AM EST
  49. Big Pharma Companies Are Betting On Regenerative Medicine - Should You?

    GuruFocus | May. 26, 2015 | 13:35PM EST
  50. Johnson & Johnson Drug Pipeline to Help it Deliver Above-Average Growth

    GuruFocus | May. 22, 2015 | 13:07PM EST
Trading Center
×

You are using adblocking software

Want access to all of Investopedia? Add us to your “whitelist”
so you'll never miss a feature!